We give the surgeon the freedom to operate www.biomendex.com
1 in 3 women will break bones 1 in 5 men Up to 20 % won’t heal properly Orthopaedic Research Society
The only intuitive material for bone regeneration 4 million potential operations per year Patent pending technology Market size of $5 B New processing method that is hard to master or copy
Product family Patented structure • Synthetic Adaptos ™ Dental • Intuitive and familiar to use 1 mm • Bonelike structure • Proven safety and efficacy Adaptos ™ Ortho • Materials in clinical use The material can be: • bent • shaped Strong bone formation Adaptos ™ Spine The material does not break
• Most important and expensive phase Why to apply funding from EU? in medical device development • The plan Grant, not a loan • Inhouse expertise generates • competitive backbone for market 70 % of the costs covered conquest • Expert coaches included • Reimbursement exp Clinical study • Med dev. Ex-VP WPs • Approach clinical experts • Development of early sales Process upscale Commercialization channels • Development of novel manufacturing process to meet the market demand
Background materials First draft ready delivered Pitch & interview Invitation to interview Contacting consultant agency on July 2018 Early milestones as preproject Q4/2018 Contract Transaction Start 3/2019 4/2019 5/2019 6/2019 7/2019 8/2019 9/2019 Results Submission Interview Writing training starts starts
Gains of the successful application process: • Large project can be executed • Inhouse expertise can be developed • Independent evaluation by EU-expert team (VCs, investors, business experts) Strong positive statement of the team, technology and BO Further interest among possible partners and funders
Recommendation to apply when: • You have developed a novel technological solution with a superior value proposition • You are tackling an important problem at European level • You have proven a strong market demand for the solution and validated it with initial pilot customers • You have tested and validated a prototype proving the benefits of the technology
Grant 50 000 € Grant 24 000 € Funding negotiations Business Finland Customership Negotiations for commercializing the technology Top 100 Most Promising Start-ups Grant 12 000 € Kasvu Open Sales Freedom-to- operate study 2 x 5000 € Project (commercialization) – 1 160 000 € permission Vet-sales For human Company start Grant 15 000 € patients Start-up Grants 3 x 24 000 € Invention/idea H1/2022 Patent Research project - 930 000 € FI127762B 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 Preclinical Funding application Tekes Preclinical Clinical EU Grant pilot study technology commercialization study study Funding for clinical 2.25 M€ study granted Seed round 400k € 120 000 € Patent app. FI20165699 (A) Collaboration: Hospital Orton Funding application Qmedical dental clinic clinical study HUS Children’s Hospital HUS Ortopedics & Traumatology First patient Funding rounds MPidea-competition (dog) Clinical study in dogs 3 rd place Academy of Finland & Tekes Collaboration: First 5+ Animal hospitals & clinics Horse patient
BIOMENDEX – PRESENT & FUTURE 2019 2020 2021 - 2022 CE-mark for the first Production cabability products for human patients Vet-product sales start Over 20 animal patients Building the sales operated successfully organization for EU- markets Seed funding round successful Product families Significant funding from: • ISO 13485 Quality Business Finland Ortho Dental • system build-up EU H2020 • ELY-keskus Clinical trials on start: Participant in a scientific Dental application human patient study (market Orthopaedic application value up to 10M€) Spine www.biomendex.com
Biomendex.com
Recommend
More recommend
